Sermorelin vs CJC-1295: Which Growth Hormone Peptide Is Right for You?
Sermorelin and CJC-1295 both stimulate growth hormone release, but differ in half-life, pulsatility, and clinical use. A physician's comparison of both peptides.
Peptide Therapy
Moderate EvidenceGrowth hormone secretagogues stimulating pulsatile GH release through complementary pituitary pathways.
Sermorelin and CJC-1295 both stimulate growth hormone release, but differ in half-life, pulsatility, and clinical use. A physician's comparison of both peptides.
Ipamorelin selectively amplifies GH pulses without raising cortisol or prolactin. Physician guide to dosing, stacking with CJC-1295, and candidacy.
A physician's evidence-based guide to peptide therapy for women — covering hormonal interactions, key peptides, dosing considerations, and who is a suitable candidate.
Evidence-based review of peptides for muscle growth. GH secretagogues, BPC-157 for recovery, safety risks, and what works based on clinical experience.
A physician's comparison of CJC-1295/Ipamorelin and tesamorelin — mechanisms, evidence, body composition effects, and which GH secretagogue suits which patient.
Evidence-based CJC-1295/Ipamorelin dosing guide by Dr. Julian Douwes. Nightly subcutaneous protocols, DAC vs no-DAC, cycling, and growth hormone optimization.
CJC-1295/Ipamorelin for fat loss and body recomposition. Dr. Julian Douwes explains growth hormone mechanisms, realistic timelines, and what the evidence supports.
CJC-1295 and Ipamorelin review by Dr. Julian Douwes. Growth hormone optimization, body composition, evidence for GH secretagogues, dosing and safety.